Novo Nordisk CEO: This is where science meets speed and scale

Mike, it's great to have you on the show. Welcome. What does this partnership with OpenAI enable and how quickly do you expect to realize results.Thank you very much, Morgan, for having me. It's a very exciting day for our company because in a nutshell, you could say this is a day where science meets speed and scale at the same time. We're partnering with OpenAI on the back of a huge data set that Novo Nordisk holds, probably second to none when it comes to diabetes and obesity, and a company technological ...